A retrospective study of clinical usage of quetiapine XR and quetiapine IR in outpatients with schizophrenia in Denmark

Human Psychopharmacology

Volumn 27, Issue 5, 2012, Pages 492-498

  Emborg, Charlotte ^a   Hallerbäck, Teresa ^b   Jörgensen, Leif ^b   Carlborg, Andreas ^c  

^a National Coordinating Investigator of the Non Interventional Study   (Denmark)

^b ASTRAZENECA R AND D   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

naturalistic study; outpatients; quetiapine extended release; quetiapine immediate release; schizophrenia; treatment choice

Indexed keywords

QUETIAPINE;

ARTICLE; DENMARK; DRUG DOSE COMPARISON; DRUG FORMULATION; DRUG MEGADOSE; FEMALE; HUMAN; LOW DRUG DOSE; MALE; MEDICAL RECORD REVIEW; OUTPATIENT; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; DELAYED-ACTION PREPARATIONS; DENMARK; DIBENZOTHIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84866667971     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.2254     Document Type: Article

References (29)

1. Altamura AC, Armadoros D, Jaeger M, Kernish R, Locklear J, Volz HP,. 2008. Importance of open access to atypical antipsychotics for the treatment of schizophrenia and bipolar disorder: a European perspective. Curr Med Res Opin 8: 2271-2282.
2. Archer T,. 2010. Neurodegeneration in schizophrenia. Expert Rev Neurother 10: 1131-1141.
3. Baldwin CM, Scott LJ,. 2009. Quetiapine extended release: in schizophrenia. CNS Drugs 23: 261-269.
4. Barnes TR, Paton C,. 2011. Antipsychotic polypharmacy in schizophrenia: benefits and risks. CNS Drugs 25: 383-399.
5. Bingefors K, Isacson D, Lindström E,. 2003. Dosage patterns of antipsychotic drugs for the treatment of schizophrenia in Swedish ambulatory clinical practise-a highly individualised therapy. Nord J Psychiatry 57: 263-269.
6. Birk Andersen T,. 2011. Danske regioner. Principper for udlevering af vederlagsfri medicin til særlige ikke-indlagte patientgrupper, der er i fortsat sygehusbehandling
7. Broekema WJ, de Groot IW, van Harten PN,. 2007. Simultaneous prescribing of atypical antipsychotics, conventional antipsychotics and anticholinergics-a European study. Pharm World Sci 29: 126-130.
8. Buchanan RW, Kreyenbuhl J, Kelly DL, et al,. 2010. The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull 1: 71-93.
9. Datto C, Berggren L, Patel JB, Eriksson H,. 2009. Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: a randomized, double-blind, crossover study in healthy adult subjects. Clin Therapeutics 31: 492-502.
10. Figueroa C, Brecher M, Hamer-Maansson JE, Winter H,. 2009. Pharmacokinetic profiles of extended release quetiapine fumarate compared with quetiapine immediate release. Prog Neuropsychopharmacol Biol Psychiatry 33: 199-204.
11. Gorwood P,. 2006. Meeting everyday challenges: antipsychotic therapy in the real world. Eur Neuropsychopharmacol 16: 156-162.
12. Hellewell JS,. 1999. Treatment-resistant schizophrenia: reviewing the options and identifying the way forward. J Clin Psychiatry 60: 14-19.
13. Johnsen E, Kroken RA, Wentzel-Larsen T, Jørgensen HA,. 2010. Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone. BMC Psychiatry 10: 26-38.
14. 2-receptor occupancy. Arch Gen Psychiatry 57: 553-559.
15. Kasper S, Brecher M, Fitton L, Jones AM,. 2004. Maintenance of long-term efficacy and safety of quetiapine in the open-label treatment of schizophrenia. Int Clin Psychopharmacol 19: 281-289.
16. Kroken RA, Johnsen E, Ruud T, Wentzel-Larsen T, Jørgensen HA,. 2009. Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study. BMC Psychiatry 9: 24-33.
17. Meulien D, Huizar K, Brecher M,. 2010. Safety and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: pooled data from randomised, double-blind, placebo-controlled studies. Hum Psychopharmacol 25: 103-115.
18. Mitchell AJ, Selmes T,. 2007. Why don't patients take their medicine? Reasons and solutions in psychiatry. Adv Psychiatr Treat 13: 336-346.
19. Naber D, Lambert M,. 2009. The CATIE and CUtLASS studies in schizophrenia: results and implications for clinicians. CNS Drugs 23: 649-659.
20. Palmer B, Pankratz VS, Bostwick JM,. 2005. The lifetime risk of suicide in schizophrenia. Arch Gen Psychiatry 62: 247-253.
21. Petersen L, Jeppesen P, Thorup A, et al,. 2005. A randomised multicentre trial of integrated standard treatment for patients with a first episode of psychotic illness. BMJ 31 (7517): 602.
22. Peuskens J, Trivedi J, Malyarov S, et al,. 2007. Prevention of schizophrenia relapse with extended release quetiapine fumarate dosed once daily: a randomized, placebo-controlled trial in clinically stable patients. Psychiatry (Edgmont) 4: 34-50.
23. Philip N, Mello K, Carpenter LL, Tyrka AR, Price LH,. 2008. Patterns of quetiapine use in psychiatric inpatients: an examination of off-label use. Ann Clin Psychiatry 20: 15-20.
24. Pompili M, Amador XF, Girardi P, et al,. 2007. Suicide risk in schizophrenia: learning from the past to change the future. Ann Gen Psychiatry 6: 10.
25. Riedel M, MÅller N, Strassnig M, Spellman I, Severus E, Moller HJ,. 2007. Quetiapine in the treatment of schizophrenia and related disorders. Neuropsychchiatr Dis Treat 3: 219-235.
26. Riedel M, Severus E, Schennach-Wolff R, et al,. 2011. Effectiveness of quetiapine in outpatients with schizophrenia assessed under "real- life" conditions. A German Clinical-Practice Evaluation Programme. J Clin Psychopharmacol 31: 120-122.
27. Simes RJ,. 2002. Clinical trials and "real world" medicine. MJA 177: 407-408.
28. Valenstein M, Ganoczy D, McCarthy JF, Myra KH,;, Lee TA, Blow FC,. 2006. Antipsychotic adherence over time among patients receiving treatment for schizophrenia: a retrospective review. J Clin Psychiatry 67: 1542-1550.
29. Wolff-Menzler C, Hasan A, Malchow B, Falkai P, Wobrock T,. 2010. Combination therapy in the treatment of schizophrenia. Pharmacopsychiatry 43: 122-129.